Clinical and Experimental Reproductive Medicine

  • 제50권1호
  • /
  • Pages.34-43
  • /
  • 2023
  • /
  • 2233-8233(pISSN)
  • /
  • 2233-8241(eISSN)
대한생식의학회 (The Korean Society for Reproductive Medicine)
권호 표지
DOI QR코드

DOI QR Code

Identification of royal jelly as a potential new drug to protect the ovarian reserve and uterus against cyclophosphamide in rats

  • Mehmet Bulbul (Department of Obstetrics and Gynecology, Karabuk University Faculty of Medicine) ;
  • Ali Tekce (Department of Obstetrics and Gynecology, Harran University Faculty of Veterinary Medicine) ;
  • Ebru Annac (Department of Histology and Embryology, Adiyaman University Faculty of Medicine) ;
  • Omer Korkmaz (Department of Obstetrics and Gynecology, Harran University Faculty of Veterinary Medicine) ;
  • Muhittin Onderci (Department of Biochemistry, Adiyaman University Faculty of Medicine) ;
  • Deniz Korkmaz (Department of Histology and Embryology, Harran University Faculty of Veterinary Medicine) ;
  • Akin Mustafa Demirci (Department of Microbiology, Harran University Faculty of Veterinary Medicine)
  • 투고 : 2022.08.02
  • 심사 : 2023.01.05
  • 발행 : 2023.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: The aim of this study was to investigate the effect of royal jelly (RJ), a powerful natural antioxidant, on cyclophosphamide-induced ovarian damage. Methods: Thirty-two Wistar albino rats were divided into four groups. Oral treatment was administered to all rats for 16 days after a single intraperitoneal injection. The control group received intraperitoneal and oral saline; the RJ group received intraperitoneal saline and 100 mg/kg/day oral RJ; the cyclophosphamide group received intraperitoneal 100 mg/kg cyclophosphamide and oral saline; and the treatment group received intraperitoneal 100 mg/kg cyclophosphamide and 100 mg/kg/day oral RJ. The groups were compared in terms of ovarian reserve tests and histopathological changes in the ovary and uterus. Results: All follicle counts were higher in the treatment group than in the cyclophosphamide group. The increase in the number of preantral follicles (p=0.001) and the decrease in the number of atretic follicles (p=0.004) were statistically significant. RJ treatment significantly improved follicular degeneration and cortical fibrosis in the ovary and epithelial and gland degeneration in the uterus due to cyclophosphamide toxicity. Conclusion: According to these results, RJ reduces cyclophosphamide-related ovarian and endometrial damage in rats. For this reason, it should be further investigated to determine its effects on reproductive function.

키워드

과제정보

We would like to thank the veterinary surgeon Elif Tosun and the staff member Nurhan Tirasci for their assistance in the rats' care, drug application, and surgery. We also acknowledge Dr. Mehmet Can Nacar for his contributions.

참고문헌

  1. Yuksel A, Bildik G, Senbabaoglu F, Akin N, Arvas M, Unal F, et al. The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells. Hum Reprod 2015;30:2926-35. https://doi.org/10.1093/humrep/dev256
  2. Han M, Cheng H, Wang J, Yu Y, Wang F, Zhu R, et al. Abnormal aggregation of myeloid-derived suppressor cells in a mouse model of cyclophosphamide-induced premature ovarian failure. Gynecol Endocrinol 2019;35:985-90. https://doi.org/10.1080/09513590.2019.1616173
  3. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 2018;36:1994-2001. https://doi.org/10.1200/JCO.2018.78.1914
  4. Kamakura M. Royalactin induces queen differentiation in honeybees. Nature 2011;473:478-83. https://doi.org/10.1038/nature10093
  5. Fujita T, Kozuka-Hata H, Ao-Kondo H, Kunieda T, Oyama M, Kubo T. Proteomic analysis of the royal jelly and characterization of the functions of its derivation glands in the honeybee. J Proteome Res 2013;12:404-11. https://doi.org/10.1021/pr300700e
  6. Buttstedt A, Moritz RF, Erler S. More than royal food: major royal jelly protein genes in sexuals and workers of the honeybee Apis mellifera. Front Zool 2013;10:72.
  7. Li J, Wu J, Begna Rundassa D, Song F, Zheng A, Fang Y. Differential protein expression in honeybee (Apis mellifera L.) larvae: underlying caste differentiation. PLoS One 2010;5:e13455.
  8. Yusuf AA, Crewe RM, Pirk CW. Turning workers into false queens: the role of exogenous pheromones in regulating reproduction in worker honey bees. J Exp Biol 2018;221(Pt 13):jeb175505.
  9. Silici S, Ekmekcioglu O, Kanbur M, Deniz K. The protective effect of royal jelly against cisplatin-induced renal oxidative stress in rats. World J Urol 2011;29:127-32. https://doi.org/10.1007/s00345-010-0543-5
  10. Khazaei F, Ghanbari E, Khazaei M. Protective effect of royal jelly against cyclophosphamide-induced thrombocytopenia and spleen and bone marrow damages in rats. Cell J 2020;22:302-9.
  11. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000;21:200-14.
  12. Luan Y, Edmonds ME, Woodruff TK, Kim SY. Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide. J Endocrinol 2019;240:243-56. https://doi.org/10.1530/JOE-18-0370
  13. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001;7:535-43. https://doi.org/10.1093/humupd/7.6.535
  14. Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, et al. Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility. Sci Transl Med 2013;5:185ra62.
  15. Lande Y, Fisch B, Tsur A, Farhi J, Prag-Rosenberg R, Ben-Haroush A, et al. Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro. Reprod Biomed Online 2017;34:104-14. https://doi.org/10.1016/j.rbmo.2016.10.005
  16. Zhang BF, Hu Y, Liu X, Cheng Z, Lei Y, Liu Y, et al. The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide. PLoS One 2018;13:e0201136.
  17. Ekiz Yilmaz T, Tasdemir M, Kaya M, Arican N, Ahishali B. The effects of magnesium sulfate on cyclophosphamide-induced ovarian damage: folliculogenesis. Acta Histochem 2020;122:151470.
  18. Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson RA, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update 2019;25:673-93. https://doi.org/10.1093/humupd/dmz027
  19. Lopez SG, Luderer U. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis. Free Radic Biol Med 2004;36:1366-77. https://doi.org/10.1016/j.freeradbiomed.2004.02.067
  20. Di Emidio G, Rossi G, Bonomo I, Alonso GL, Sferra R, Vetuschi A, et al. The natural carotenoid crocetin and the synthetic tellurium compound as101 protect the ovary against cyclophosphamide by modulating SIRT1 and mitochondrial markers. Oxid Med Cell Longev 2017;2017:8928604.
  21. Ghanbari E, Nejati V, Najafi G, Khazaei M, Babaei M. Study on the effect of royal jelly on reproductive parameters in streptozotocin-induced diabetic rats. Int J Fertil Steril 2015;9:113-20.
  22. Ab Hamid N, Abu Bakar AB, Mat Zain AA, Nik Hussain NH, Othman ZA, Zakaria Z, et al. Composition of royal jelly (RJ) and its anti-androgenic effect on reproductive parameters in a polycystic ovarian syndrome (PCOS) animal model. Antioxidants (Basel) 2020;9:499.
  23. Tohamy HG, El-Neweshy MS, Soliman MM, Sayed S, Shukry M, Ghamry HI, et al. Protective potential of royal jelly against hydroxyurea-induced hepatic injury in rats via antioxidant, anti-inflammatory, and anti-apoptosis properties. PLoS One 2022;17:e0265261.
  24. Valiollahpoor Amiri M, Deldar H, Ansari Pirsaraei Z. Impact of supplementary royal jelly on in vitro maturation of sheep oocytes: genes involved in apoptosis and embryonic development. Syst Biol Reprod Med 2016;62:31-8. https://doi.org/10.3109/19396368.2015.1088102
  25. D'Avila AM, Biolchi V, Capp E, Corleta HV. Age, anti-Mullerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide. J Ovarian Res 2015;8:82.
  26. Eshtiyaghi M, Deldar H, Pirsaraei ZA, Shohreh B. Royal jelly may improve the metabolism of glucose and redox state of ovine oocytes matured in vitro and embryonic development following in vitro fertilization. Theriogenology 2016;86:2210-21. https://doi.org/10.1016/j.theriogenology.2016.07.019
  27. Ghanbari E, Khazaei MR, Khazaei M, Nejati V. Royal jelly promotes ovarian follicles growth and increases steroid hormones in immature rats. Int J Fertil Steril 2018;11:263-9.
  28. Elnagar SA. Royal jelly counteracts bucks' "summer infertility". Anim Reprod Sci 2010;121:174-80. https://doi.org/10.1016/j.anireprosci.2010.05.008
  29. Tal R, Seifer DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol 2017;217:129-40. https://doi.org/10.1016/j.ajog.2017.02.027